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Ssmoking habits, hypertension and hyperlipidaemia and in use of UH/LMWH and
drug-eluting stents during the procedure. RA patients were more likely to be pre-
treated with aspirin, clopidogrel and to receive bivalirudin. FA patients were more
likely to had previous myocardial infarction, previous PCI, previous coronary CABG
and to receive GP IIb/IIIa. There were 600 patients (41.1%) with STEMI and 858
(58.9%) with UA/NSTEMI. More patients with STEMI underwent PCI through FA.
There was no difference in 30-days mortality between the RA and FA group (5.5% vs.
6.3%; HR 1.2; 95% CI 0.73–2.0; p ¼ 0.46).
Conclusions: In this study, PCI through radial artery access was not associated with
reduced 30-days mortality in octogenarians with acute coronary syndromes. Properly
designed randomised clinical trial is needed to test whether radial artery access may
decrease mortality in octogenarians.
TCT-47
Angiographic And Procedural Outcome Of Percutaneous Coronary Intervention
With The STENTYS Self-Apposing Coronary Stent In Patients Not Treated
For STEMI.
Huangling Lu1, Maik J. Grundeken2, Jan Baan Jr3, Marije M. Vis2,
Jose P. Henriques2, Jan Piek4, Joanna J. Wykrzykowska5, Jan G. Tijssen2,
Karel T. Koch2, Robbert J. de Winter2
1Academic Medical Center, Amsterdam, Noord-Holland, 2Academic Medical Center -
University of Amsterdam, Amsterdam, Netherlands, 3AMC Medical Center,
Amsterdam, Amsterdam, Netherlands, 4Academic Medical Center, Amsterdam,
Netherlands, 5Academic Medical Center - University of Amsterdam, Amsterdam, MI
Background: Treatment of complex lesions in coronary arteries with aneurysms,
ectasia, or tapering remains challenging due to a high risk of vessel wall-stent diameter
mismatch. The self-apposing STENTYS stent (STENTYS SA, Paris, France) is
designed to adjust to variable vessel diameters, which may optimize the vessel wall-
stent match and reduce the risk of stent malapposition. STENTYS is extensively
evaluated in ST-segment elevation myocardial infarction (STEMI) patients, but there
is a paucity of data of other treatment indications. We evaluated the feasibility and
safety of the STENTYS stent in complex lesions with a high risk of diameter
mismatch.
Methods: We included consecutive patients treated with STENTYS between April
2010 and June 2013 because of angiographic characteristics with a high risk of
diameter mismatch, including aneurysms, ectasia, tapering, bifurcation lesions, and
saphenous vein graft (SVG). STEMI patients were excluded. Angiographic success
was deﬁned as ﬁnal residual stenosis <5 % in the target vessel with TIMI 3 ﬂow.
Procedural success was deﬁned as angiographic success without in-hospital cardiac
death, myocardial infarction (MI) or target vessel revascularization (TVR).
Results: A total of 87 patients were included, mean age was 6512 years. Indications
for the STENTYS stent were; aneurysm: 25(29%), ectasia: 21(24%), tapering:
27(31%), bifurcation: 22(25%), and SVG: 9(10%). In some target vessels 2 indi-
cations applied. Angiographic and procedural success was achieved in 92% and 91%
respectively. In 6(8%) patients there was 5% residual stenosis on visual estimate,
which might improve over time due to the stents self-apposing properties, 1 patient
suffered from an in-hospital MI. No peri-procedural complications occurred.
Conclusions: Early angiographic and procedural success of treatment with the
STENTYS stent, in patients other than STEMI, are favourable. This single-center
experience provides novel insights of angiographic and procedural outcome in
complex lesions with a high risk of diameter mismatch. Long-term clinical follow-up,
which will be available at TCT, is needed to evaluate whether the self-apposing stent
technique translates into favourable clinical outcomes.
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Background: Soｍe trials have suggested that transradial intervention (TRI) reduces
vascular complications and bleeding compared with transfemoral intervention (TFI).
However, the long term outcomes are still not clear in patients with ST-segment
elevation myocardial infarction (STEMI). In this study, we aimed to assess the
feasibility and the long term outcomes of TRI in patients with who underwent primary
percutaneous coronary intervention (PCI).
Methods: This study was multicenter,retrospective observational study. Between
January 2006 and December 2010, a total of 550 STEMI patients underwent primary
PCI. Out of these patients, TRI was performed in 208 patients and TFI was performed
in 342 patients. Mean follow-up period was 3325 months. Outcome measures were
in-hospital complications (all-cause death,recurrent myocardial infarction,stroke,major
bleeding) and major adverse cardiovascular events (MACE: all-cause death,target
vessel revascularization (TVR), recurrent myocardial infarction, admission of heart
failure) at 3 years.
Results: There was no statistical difference in patients characteristics between two
groups. During the initial hospitalization, the complications rate was 2.9% in TRIB16 JACC Vol 62/18/Suppl B j October 27–Novembegroup and 9.4% in TFI group (P¼0.004). Kaplan-Meier survival curves showed that
the freedom from MACE was 76.9% in TRI vs 68.4% in TFI at three years(P¼0.03).Conclusions: Both the in-hospital complications and the difference in freedom from
MACE at 3 years were statistically lower in TRI group compared with TFI group.Miscellaneous Coronary Intervention
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Background: Percutaneous coronary intervention (PCI) in the setting of acute
myocardial infarction (MI) is known to predict stent thrombosis. However, the
association between the spectrum of clinical presentation and stent thrombosis after
PCI has not been well deﬁned. This study aims to compare the stent thrombosis rates
across the acuity of clinical presentation for PCI.
Methods: The study included a cohort of 12198 consecutive patients who underwent
PCI. Patients were categorized according to their clinical presentation: stable angina
pectoris (SAP, n¼3700), unstable angina pectoris (UAP, n¼2845), non ST-segment
elevation MI (NSTEMI, n¼4083), and ST-segment elevation MI (STEMI, n¼1570).
The ARC-deﬁned stent thrombosis rates were compared among the groups.
Results: Antiplatelet loading was similar across groups (85% overall). The use of
drug-eluting stents (DES) in STEMI pts. was 51.3%, 73% in NSTEMI, 77.4% in
UAP, and 77.7% in SAP. One-year deﬁnite stent thrombosis rates were highest in
STEMI compared to other groups. (Figure) Similarly, rates of probable stent throm-
bosis increased with the acuity of the clinical presentation: lowest in UAP and highest
in STEMI. The majority of deﬁnite (71.4%) and probable (66.6%) stent thrombosis
occurred early (within 30 days). The rates of death and myocardial infarction corre-
sponded with the acuity of clinical presentation.
Conclusions: In patients undergoing PCI, the acuity of clinical presentation corre-
sponds to an increase in the incidence of stent thrombosis. A pro-inﬂammatory milieu
promoting thrombosis and delaying endothelial healing may contribute to this.r 1, 2013 j TCT Abstracts/ORAL/Miscellaneous Coronary Intervention
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Background: A strong relationship between platelet reactivity and stent thrombosis
(ST) after DES implantation was recently conﬁrmed in the prospective, multicenter
ADAPT-DES study. We herein seek to identify the angiographic predictors of 2-year
ST from this large-scale study.
Methods: Angiographic analyses were performed by an independent angiographic
core laboratory for all ST thromboses. According to a pre-speciﬁed substudy,
propensity-adjusted multivariable analysis was performed to determine angiographic
predictors of 2-year ST.
Results: Among the 8,583 patients included in the ADAPT-DES study, 92 (1.1%) pts
had ST at 2 year of follow-up. Target lesion-related ST were identiﬁed in 77 pts (82
lesions) and clinically matched with 153 pts (196 lesions) without ST. Pts with ST
were more likely to have three vessel disease, longer target lesions, more lesions
containing thrombus, moderate-to-severe calciﬁcation, ACC/AHA type C class, total
occlusions, and in saphenous vein grafts. After propensity-adjusted multivariable
analysis, ACC/AHA type C lesion (HR [95%C] ¼ 1.73 [1.05, 2.86], p¼0.03), the
presence of a total occlusion (HR [95%C] ¼ 1.39 [1.10, 1.76], p¼0.005), and PRU
>208 (HR [95%C] ¼ 1.61 [1.01, 2.57], p¼0.045) were independent predictors of ST
2 years after DES.
Conclusions: From the large-scale ADAPT-DES study, complex lesion (type C) and
total occlusions remain strong angiographic predictors of 2-year ST in the DES era.
Future studies are required to determine methods to reduce ST in the high-risk lesions,
especially in pts with high platelet reactivity on clopidogrel.
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Background: Chronic total coronary occlusion (CTO) is a frequent ﬁnding in patients
with ischemic heart disease. Our aim was to evaluate the prognostic impact of CTO on
long-term survival in patients with different severity of ischemic heart disease at the
level of one whole nation.
Methods: The study population included all consecutive patients registered in the
SCAAR registry (Swedish Coronary Angiography and Angioplasty Registry) from
2005 to 2012 who underwent angiography or PCI in Sweden. Patients with previous
coronary artery bypass graft surgery were excluded. The patients with CTO and
without CTO (no-CTO) were compared using Cox proportional-hazards regression
adjusted for the following covariates: age, indication, extent of coronary artery
disease, smoking, hypertension, hyperlipidemia, diabetes, year of intervention, prior
infarction, prior PCI, hospital and complications. Interaction test was performed
between the presence CTO and the different severity of ischemic heart disease e.g.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrone-vessel disease (1VD), two-vessel disease (2VD), three-vessel disease (3VD) and
left main (LM).
Results: The total of 91,154 patients were included in the study of which 14,609 had
a CTO. Median follow-up was 3 years. The total number of events was 9084. CTO
was an independent predictor of mortality (HR 1.29; 95%CI 1.22-1.37; P<0.001).
There was no interaction between the presence of CTO and severity of ischemic heart
disease (P¼0.32) signifying that CTO is of equal negative prognostic importance in all
subgroups. Compared to 1VD, the mortality risk was higher in 2VD (HR 1.17; 95%CI
1.11-1.24; P<0.001), 3VD (HR 1.47; 95%CI 1.38-1.58; P<0.001) and LM (HR 1.87;
95%CI 1.72-2.02; P<0.001).
Conclusions: Our study is based on the largest CTO cohort so far. The presence of
CTO confers worsening long-term survival in all subsets of coronary artery disease.
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Background: Despite recent high success rates owing to the development of new
strategies such as the retrograde approach, the procedural complications and their
management related percutaneous coronary intervention (PCI) of chronic total
occlusions (CTOs) have not been fully evaluated.
Methods: The aim of this study was to investigate in-hospital outcomes and compare
the frequency of the complications between via the retrograde approach vs. via
antegrade approach. The complications included major adverse cardiac and cerebro-
vascular events (MACCE) (deﬁned as death, myocardial infarction [MI], emergent
coronary bypass surgery, repeat PCI, or stroke), bleeding of clinical signiﬁcance, and
he procedural complications such as acute or sub-acute occlusion, distal embolization,
coronary dissection, and coronary perforation.
Results: Of 1,014 CTOs in 943 patients who underwent PCI between 2005 and 2010,
278 CTOs (27.6%) were attempted using the retrograde approach. The overall
procedural success rate was 92.4% (937/1014). The complication was the second
reason for suspended CTO procedure (7.8%; 6/77). No signiﬁcant difference was
observed in the frequency of the complications between antegrade approach and
retrograde approach except the frequency of coronary perforation that was higher in
the patients treated with retrograde approach. (Table).
Conclusions: Although the higher rate of coronary perforation in the patients treated
with retrograde approach, all cases were solved with optimal treatments in the cath-lab
and in-hospital MACCE was acceptable. Retrograde approach could be the one of the
option for the failed case wi.TCT-53
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Background: Chronic total occlusions (CTO) are complex procedures aiming to
improve the symptoms and outcomes of patients. Although a signiﬁcantly positive
ischemia/viability test is accepted by guidelines as enough to trigger a CTO attempt,
there is still controversy whether silent ischemia patients can beneﬁt as much as
symptomatic patients from this procedure.
Methods: A total of 1343 consecutive patients underwent percutaneous coronary
intervention (PCI) at our center between 2004 and 2013. We compared baseline and
procedural characteristics as well as mid-term outcome in patients with silent or
symptomatic ischemia.acts/ORAL/Miscellaneous Coronary Intervention B17
